Nicotine Drug For Further Processing - NDC Database

NDC Database
6 labelers

Nicotine Drug For Further Processing

National Drug Code (NDC) records including drug products, labelers, dosage forms, strengths, substances and marketing information.

DRUG FOR FURTHER PROCESSING

Browse NDC

86
All
41
Bulk Ingredient
45
Drug for Further Processing
Last Marketing Date
2025-02-03
Data Source
FDA
First Marketing Date
1996-05-22
Advertise Here
Reach qualified buyers

Boost your visibility among pharma sourcing professionals and potential buyers.

  • Grow your business with qualified leads
  • GDS reports on your ad performance
  • Targeted to this product's audience
  • Direct enquiries from buyers
  • Visibility to pharma professionals
Buy This Ad Space
NDC Records Timeline (45 records)
Clear
2025
01 Feb
DRUG FOR FURTHER PROCESSING

NDC

11014-0742

Labeler

Catalent Pharma Solutions, LLC

Nonproprietary Name

Nicotine

Marketing Category

DRUG FOR FURTHER PROCESSING

Dosage Form

LOZENGE

Strength

2 mg/1

Start Marketing: 2025-02-01

Substance

NICOTINE

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

2025-02-01

End Marketing Date

-

Listing / Certification

2026-12-31

2025
03 Feb
DRUG FOR FURTHER PROCESSING

NDC

11014-0743

Labeler

Catalent Pharma Solutions, LLC

Nonproprietary Name

Nicotine

Marketing Category

DRUG FOR FURTHER PROCESSING

Dosage Form

LOZENGE

Strength

4 mg/1

Start Marketing: 2025-02-03

Substance

NICOTINE

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

2025-02-03

End Marketing Date

-

Listing / Certification

2026-12-31

2025
01 Jan
DRUG FOR FURTHER PROCESSING

NDC

11014-0744

Labeler

Catalent Pharma Solutions, LLC

Nonproprietary Name

Nicotine

Marketing Category

DRUG FOR FURTHER PROCESSING

Dosage Form

LOZENGE

Strength

4 mg/1

Start Marketing: 2025-01-01

Substance

NICOTINE

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

2025-01-01

End Marketing Date

-

Listing / Certification

2026-12-31

2025
01 Jan
DRUG FOR FURTHER PROCESSING

NDC

11014-0745

Labeler

Catalent Pharma Solutions, LLC

Nonproprietary Name

Nicotine

Marketing Category

DRUG FOR FURTHER PROCESSING

Dosage Form

LOZENGE

Strength

2 mg/1

Start Marketing: 2025-01-01

Substance

NICOTINE

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

2025-01-01

End Marketing Date

-

Listing / Certification

2026-12-31

2020
21 Feb
Dr. Reddy's Laboratories Inc.
DRUG FOR FURTHER PROCESSING

NDC

43598-484

Labeler

Dr. Reddy's Laboratories Inc.

Nonproprietary Name

Nicotine Polacrilex

Marketing Category

DRUG FOR FURTHER PROCESSING

Dosage Form

LOZENGE

Strength

2 mg/1

Start Marketing: 2020-02-21

Substance

NICOTINE

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

2020-02-21

End Marketing Date

-

Listing / Certification

2027-12-31

2020
21 Feb
Dr. Reddy's Laboratories Inc.
DRUG FOR FURTHER PROCESSING

NDC

43598-485

Labeler

Dr. Reddy's Laboratories Inc.

Nonproprietary Name

Nicotine Polacrilex

Marketing Category

DRUG FOR FURTHER PROCESSING

Dosage Form

LOZENGE

Strength

4 mg/1

Start Marketing: 2020-02-21

Substance

NICOTINE

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

2020-02-21

End Marketing Date

-

Listing / Certification

2027-12-31

2020
08 Jan
Dr. Reddy's Laboratories Inc.
DRUG FOR FURTHER PROCESSING

NDC

43598-486

Labeler

Dr. Reddy's Laboratories Inc.

Nonproprietary Name

Nicotine Polacrilex

Marketing Category

DRUG FOR FURTHER PROCESSING

Dosage Form

LOZENGE

Strength

2 mg/1

Start Marketing: 2020-01-08

Substance

NICOTINE

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

2020-01-08

End Marketing Date

-

Listing / Certification

2027-12-31

2020
08 Jan
Dr. Reddy's Laboratories Inc.
DRUG FOR FURTHER PROCESSING

NDC

43598-487

Labeler

Dr. Reddy's Laboratories Inc.

Nonproprietary Name

Nicotine Polacrilex

Marketing Category

DRUG FOR FURTHER PROCESSING

Dosage Form

LOZENGE

Strength

4 mg/1

Start Marketing: 2020-01-08

Substance

NICOTINE

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

2020-01-08

End Marketing Date

-

Listing / Certification

2027-12-31

2020
01 Oct
Dr. Reddy's Laboratories Inc.
DRUG FOR FURTHER PROCESSING

NDC

43598-488

Labeler

Dr. Reddy's Laboratories Inc.

Nonproprietary Name

Nicotine Polacrilex

Marketing Category

DRUG FOR FURTHER PROCESSING

Dosage Form

LOZENGE

Strength

2 mg/1

Start Marketing: 2020-10-01

Substance

NICOTINE

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

2020-10-01

End Marketing Date

-

Listing / Certification

2027-12-31

2020
01 Oct
Dr. Reddy's Laboratories Inc.
DRUG FOR FURTHER PROCESSING

NDC

43598-489

Labeler

Dr. Reddy's Laboratories Inc.

Nonproprietary Name

Nicotine Polacrilex

Marketing Category

DRUG FOR FURTHER PROCESSING

Dosage Form

LOZENGE

Strength

4 mg/1

Start Marketing: 2020-10-01

Substance

NICOTINE

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

2020-10-01

End Marketing Date

-

Listing / Certification

2027-12-31

2005
01 Jan
Fertin Pharma A/S
DRUG FOR FURTHER PROCESSING

NDC

63443-0101

Labeler

Fertin Pharma A/S

Nonproprietary Name

nicotine polacrilex

Marketing Category

DRUG FOR FURTHER PROCESSING

Dosage Form

GUM, CHEWING

Strength

2 mg/1

Start Marketing: 2005-01-01

Substance

NICOTINE

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

2005-01-01

End Marketing Date

-

Listing / Certification

2027-12-31

2006
30 Oct
Fertin Pharma A/S
DRUG FOR FURTHER PROCESSING

NDC

63443-0102

Labeler

Fertin Pharma A/S

Nonproprietary Name

nicotine polacrilex

Marketing Category

DRUG FOR FURTHER PROCESSING

Dosage Form

GUM, CHEWING

Strength

2 mg/1

Start Marketing: 2006-10-30

Substance

NICOTINE

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

2006-10-30

End Marketing Date

-

Listing / Certification

2027-12-31

2006
13 Jun
Fertin Pharma A/S
DRUG FOR FURTHER PROCESSING

NDC

63443-0121

Labeler

Fertin Pharma A/S

Nonproprietary Name

nicotine polacrilex

Marketing Category

DRUG FOR FURTHER PROCESSING

Dosage Form

GUM, CHEWING

Strength

2 mg/1

Start Marketing: 2006-06-13

Substance

NICOTINE

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

2006-06-13

End Marketing Date

-

Listing / Certification

2027-12-31

2005
01 Jan
Fertin Pharma A/S
DRUG FOR FURTHER PROCESSING

NDC

63443-0201

Labeler

Fertin Pharma A/S

Nonproprietary Name

nicotine polacrilex

Marketing Category

DRUG FOR FURTHER PROCESSING

Dosage Form

GUM, CHEWING

Strength

4 mg/1

Start Marketing: 2005-01-01

Substance

NICOTINE

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

2005-01-01

End Marketing Date

-

Listing / Certification

2027-12-31

2006
30 Oct
Fertin Pharma A/S
DRUG FOR FURTHER PROCESSING

NDC

63443-0202

Labeler

Fertin Pharma A/S

Nonproprietary Name

nicotine polacrilex

Marketing Category

DRUG FOR FURTHER PROCESSING

Dosage Form

GUM, CHEWING

Strength

4 mg/1

Start Marketing: 2006-10-30

Substance

NICOTINE

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

2006-10-30

End Marketing Date

-

Listing / Certification

2027-12-31

2006
13 Jun
Fertin Pharma A/S
DRUG FOR FURTHER PROCESSING

NDC

63443-0221

Labeler

Fertin Pharma A/S

Nonproprietary Name

nicotine polacrilex

Marketing Category

DRUG FOR FURTHER PROCESSING

Dosage Form

GUM, CHEWING

Strength

4 mg/1

Start Marketing: 2006-06-13

Substance

NICOTINE

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

2006-06-13

End Marketing Date

-

Listing / Certification

2027-12-31

2022
10 Feb
Fertin Pharma A/S
DRUG FOR FURTHER PROCESSING

NDC

63443-0838

Labeler

Fertin Pharma A/S

Nonproprietary Name

Nicotine Polacrilex

Marketing Category

DRUG FOR FURTHER PROCESSING

Dosage Form

GUM, CHEWING

Strength

2 mg/1

Start Marketing: 2022-02-10

Substance

NICOTINE

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

2022-02-10

End Marketing Date

-

Listing / Certification

2027-12-31

2022
10 Feb
Fertin Pharma A/S
DRUG FOR FURTHER PROCESSING

NDC

63443-0839

Labeler

Fertin Pharma A/S

Nonproprietary Name

Nicotine Polacrilex

Marketing Category

DRUG FOR FURTHER PROCESSING

Dosage Form

GUM, CHEWING

Strength

4 mg/1

Start Marketing: 2022-02-10

Substance

NICOTINE

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

2022-02-10

End Marketing Date

-

Listing / Certification

2027-12-31

2011
11 Oct
Fertin Pharma A/S
DRUG FOR FURTHER PROCESSING

NDC

63443-1032

Labeler

Fertin Pharma A/S

Nonproprietary Name

nicotine polacrilex

Marketing Category

DRUG FOR FURTHER PROCESSING

Dosage Form

GUM, CHEWING

Strength

2 mg/1

Start Marketing: 2011-10-11

Substance

NICOTINE

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

2011-10-11

End Marketing Date

-

Listing / Certification

2027-12-31

2011
11 Oct
Fertin Pharma A/S
DRUG FOR FURTHER PROCESSING

NDC

63443-1033

Labeler

Fertin Pharma A/S

Nonproprietary Name

nicotine polacrilex

Marketing Category

DRUG FOR FURTHER PROCESSING

Dosage Form

GUM, CHEWING

Strength

4 mg/1

Start Marketing: 2011-10-11

Substance

NICOTINE

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

2011-10-11

End Marketing Date

-

Listing / Certification

2027-12-31

2014
26 Jun
Fertin Pharma A/S
DRUG FOR FURTHER PROCESSING

NDC

63443-1151

Labeler

Fertin Pharma A/S

Nonproprietary Name

nicotine polacrilex

Marketing Category

DRUG FOR FURTHER PROCESSING

Dosage Form

GUM, CHEWING

Strength

2 mg/1

Start Marketing: 2014-06-26

Substance

NICOTINE

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

2014-06-26

End Marketing Date

-

Listing / Certification

2027-12-31

2014
26 Jun
Fertin Pharma A/S
DRUG FOR FURTHER PROCESSING

NDC

63443-1152

Labeler

Fertin Pharma A/S

Nonproprietary Name

nicotine polacrilex

Marketing Category

DRUG FOR FURTHER PROCESSING

Dosage Form

GUM, CHEWING

Strength

4 mg/1

Start Marketing: 2014-06-26

Substance

NICOTINE

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

2014-06-26

End Marketing Date

-

Listing / Certification

2027-12-31

2016
31 Aug
Fertin Pharma A/S
DRUG FOR FURTHER PROCESSING

NDC

63443-1560

Labeler

Fertin Pharma A/S

Nonproprietary Name

nicotine polacrilex

Marketing Category

DRUG FOR FURTHER PROCESSING

Dosage Form

GUM, CHEWING

Strength

2 mg/1

Start Marketing: 2016-08-31

Substance

NICOTINE

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

2016-08-31

End Marketing Date

-

Listing / Certification

2027-12-31

2016
31 Aug
Fertin Pharma A/S
DRUG FOR FURTHER PROCESSING

NDC

63443-1561

Labeler

Fertin Pharma A/S

Nonproprietary Name

nicotine polacrilex

Marketing Category

DRUG FOR FURTHER PROCESSING

Dosage Form

GUM, CHEWING

Strength

4 mg/1

Start Marketing: 2016-08-31

Substance

NICOTINE

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

2016-08-31

End Marketing Date

-

Listing / Certification

2027-12-31

2018
24 Sep
Fertin Pharma A/S
DRUG FOR FURTHER PROCESSING

NDC

63443-2853

Labeler

Fertin Pharma A/S

Nonproprietary Name

nicotine polacrilex

Marketing Category

DRUG FOR FURTHER PROCESSING

Dosage Form

GUM, CHEWING

Strength

2 mg/1

Start Marketing: 2018-09-24

Substance

NICOTINE

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

2018-09-24

End Marketing Date

-

Listing / Certification

2027-12-31

2018
24 Sep
Fertin Pharma A/S
DRUG FOR FURTHER PROCESSING

NDC

63443-2854

Labeler

Fertin Pharma A/S

Nonproprietary Name

nicotine polacrilex

Marketing Category

DRUG FOR FURTHER PROCESSING

Dosage Form

GUM, CHEWING

Strength

4 mg/1

Start Marketing: 2018-09-24

Substance

NICOTINE

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

2018-09-24

End Marketing Date

-

Listing / Certification

2027-12-31

2020
01 Jan
Fertin Pharma A/S
DRUG FOR FURTHER PROCESSING

NDC

63443-3670

Labeler

Fertin Pharma A/S

Nonproprietary Name

Nicotine Polacrilex Lozenges 4 mg Mint

Marketing Category

DRUG FOR FURTHER PROCESSING

Dosage Form

LOZENGE

Strength

4 mg/1

Start Marketing: 2020-01-01

Substance

NICOTINE

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

2020-01-01

End Marketing Date

-

Listing / Certification

2026-12-31

2020
01 Jan
Fertin Pharma A/S
DRUG FOR FURTHER PROCESSING

NDC

63443-3675

Labeler

Fertin Pharma A/S

Nonproprietary Name

Nicotine Polacrilex Lozenges 2mg Mint

Marketing Category

DRUG FOR FURTHER PROCESSING

Dosage Form

LOZENGE

Strength

2 mg/1

Start Marketing: 2020-01-01

Substance

NICOTINE

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

2020-01-01

End Marketing Date

-

Listing / Certification

2026-12-31

2020
01 Oct
Fertin Pharma A/S
DRUG FOR FURTHER PROCESSING

NDC

63443-3676

Labeler

Fertin Pharma A/S

Nonproprietary Name

Nicotine Polacrilex

Marketing Category

DRUG FOR FURTHER PROCESSING

Dosage Form

LOZENGE

Strength

2 mg/1

Start Marketing: 2020-10-01

Substance

NICOTINE

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

2020-10-01

End Marketing Date

-

Listing / Certification

2026-12-31

2020
01 Oct
Fertin Pharma A/S
DRUG FOR FURTHER PROCESSING

NDC

63443-3677

Labeler

Fertin Pharma A/S

Nonproprietary Name

Nicotine Polacrilex

Marketing Category

DRUG FOR FURTHER PROCESSING

Dosage Form

LOZENGE

Strength

4 mg/1

Start Marketing: 2020-10-01

Substance

NICOTINE

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

2020-10-01

End Marketing Date

-

Listing / Certification

2026-12-31

2020
01 Sep
Fertin Pharma A/S
DRUG FOR FURTHER PROCESSING

NDC

63443-3678

Labeler

Fertin Pharma A/S

Nonproprietary Name

Nicotine Polacrilex

Marketing Category

DRUG FOR FURTHER PROCESSING

Dosage Form

LOZENGE

Strength

2 mg/1

Start Marketing: 2020-09-01

Substance

NICOTINE

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

2020-09-01

End Marketing Date

-

Listing / Certification

2026-12-31

2020
01 Sep
Fertin Pharma A/S
DRUG FOR FURTHER PROCESSING

NDC

63443-3679

Labeler

Fertin Pharma A/S

Nonproprietary Name

Nicotine Polacrilex

Marketing Category

DRUG FOR FURTHER PROCESSING

Dosage Form

LOZENGE

Strength

4 mg/1

Start Marketing: 2020-09-01

Substance

NICOTINE

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

2020-09-01

End Marketing Date

-

Listing / Certification

2026-12-31

2019
30 Jun
Fertin Pharma A/S
DRUG FOR FURTHER PROCESSING

NDC

63443-5080

Labeler

Fertin Pharma A/S

Nonproprietary Name

nicotine polacrilex

Marketing Category

DRUG FOR FURTHER PROCESSING

Dosage Form

GUM, CHEWING

Strength

2 mg/1

Start Marketing: 2019-06-30

Substance

NICOTINE

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

2019-06-30

End Marketing Date

-

Listing / Certification

2027-12-31

2019
30 Jun
Fertin Pharma A/S
DRUG FOR FURTHER PROCESSING

NDC

63443-5081

Labeler

Fertin Pharma A/S

Nonproprietary Name

nicotine polacrilex

Marketing Category

DRUG FOR FURTHER PROCESSING

Dosage Form

GUM, CHEWING

Strength

4 mg/1

Start Marketing: 2019-06-30

Substance

NICOTINE

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

2019-06-30

End Marketing Date

-

Listing / Certification

2027-12-31

2022
01 Jun
Haleon US Holdings LLC
DRUG FOR FURTHER PROCESSING

NDC

0135-1501

Labeler

Haleon US Holdings LLC

Nonproprietary Name

nicotine polacrilex

Marketing Category

DRUG FOR FURTHER PROCESSING

Dosage Form

LOZENGE

Strength

2 mg/1

Start Marketing: 2022-06-01

Substance

NICOTINE

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

2022-06-01

End Marketing Date

-

Listing / Certification

2026-12-31

2022
01 Jun
Haleon US Holdings LLC
DRUG FOR FURTHER PROCESSING

NDC

0135-1502

Labeler

Haleon US Holdings LLC

Nonproprietary Name

nicotine polacrilex

Marketing Category

DRUG FOR FURTHER PROCESSING

Dosage Form

LOZENGE

Strength

4 mg/1

Start Marketing: 2022-06-01

Substance

NICOTINE

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

2022-06-01

End Marketing Date

-

Listing / Certification

2026-12-31

2022
01 Jun
Haleon US Holdings LLC
DRUG FOR FURTHER PROCESSING

NDC

58316-006

Labeler

Haleon US Holdings LLC

Nonproprietary Name

nicotine

Marketing Category

DRUG FOR FURTHER PROCESSING

Dosage Form

PATCH, EXTENDED RELEASE

Strength

7 mg/24h

Start Marketing: 2022-06-01

Substance

NICOTINE

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

2022-06-01

End Marketing Date

-

Listing / Certification

2026-12-31

2022
01 Jun
Haleon US Holdings LLC
DRUG FOR FURTHER PROCESSING

NDC

58316-007

Labeler

Haleon US Holdings LLC

Nonproprietary Name

nicotine

Marketing Category

DRUG FOR FURTHER PROCESSING

Dosage Form

PATCH, EXTENDED RELEASE

Strength

14 mg/24h

Start Marketing: 2022-06-01

Substance

NICOTINE

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

2022-06-01

End Marketing Date

-

Listing / Certification

2026-12-31

2022
01 Jun
Haleon US Holdings LLC
DRUG FOR FURTHER PROCESSING

NDC

58316-008

Labeler

Haleon US Holdings LLC

Nonproprietary Name

nicotine

Marketing Category

DRUG FOR FURTHER PROCESSING

Dosage Form

PATCH, EXTENDED RELEASE

Strength

21 mg/24h

Start Marketing: 2022-06-01

Substance

NICOTINE

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

2022-06-01

End Marketing Date

-

Listing / Certification

2026-12-31

2022
01 Jun
Haleon US Holdings LLC
DRUG FOR FURTHER PROCESSING

NDC

58316-009

Labeler

Haleon US Holdings LLC

Nonproprietary Name

nicotine

Marketing Category

DRUG FOR FURTHER PROCESSING

Dosage Form

PATCH, EXTENDED RELEASE

Strength

7 mg/24h

Start Marketing: 2022-06-01

Substance

NICOTINE

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

2022-06-01

End Marketing Date

-

Listing / Certification

2026-12-31

2022
01 Jun
Haleon US Holdings LLC
DRUG FOR FURTHER PROCESSING

NDC

58316-010

Labeler

Haleon US Holdings LLC

Nonproprietary Name

nicotine

Marketing Category

DRUG FOR FURTHER PROCESSING

Dosage Form

PATCH, EXTENDED RELEASE

Strength

14 mg/24h

Start Marketing: 2022-06-01

Substance

NICOTINE

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

2022-06-01

End Marketing Date

-

Listing / Certification

2026-12-31

2022
01 Jun
Haleon US Holdings LLC
DRUG FOR FURTHER PROCESSING

NDC

58316-011

Labeler

Haleon US Holdings LLC

Nonproprietary Name

nicotine

Marketing Category

DRUG FOR FURTHER PROCESSING

Dosage Form

PATCH, EXTENDED RELEASE

Strength

21 mg/24h

Start Marketing: 2022-06-01

Substance

NICOTINE

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

2022-06-01

End Marketing Date

-

Listing / Certification

2026-12-31

2022
01 Jul
L Perrigo Company
DRUG FOR FURTHER PROCESSING

NDC

50941-734

Labeler

L Perrigo Company

Nonproprietary Name

nicotine polacrilex

Marketing Category

DRUG FOR FURTHER PROCESSING

Dosage Form

LOZENGE

Strength

2 mg/1

Start Marketing: 2022-07-01

Substance

NICOTINE

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

2022-07-01

End Marketing Date

-

Listing / Certification

2026-12-31

2022
01 Jul
L Perrigo Company
DRUG FOR FURTHER PROCESSING

NDC

50941-957

Labeler

L Perrigo Company

Nonproprietary Name

nicotine polacrilex

Marketing Category

DRUG FOR FURTHER PROCESSING

Dosage Form

LOZENGE

Strength

4 mg/1

Start Marketing: 2022-07-01

Substance

NICOTINE

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

2022-07-01

End Marketing Date

-

Listing / Certification

2026-12-31

1996
22 May
DRUG FOR FURTHER PROCESSING

NDC

28663-009

Labeler

McNeil AB

Nonproprietary Name

Nicotine

Marketing Category

DRUG FOR FURTHER PROCESSING

Dosage Form

SPRAY, METERED

Strength

10 mg/mL

Start Marketing: 1996-05-22

Substance

NICOTINE

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

1996-05-22

End Marketing Date

-

Listing / Certification

2026-12-31

Limited-Time Offer
Advertise on PharmaJungle - Free for 30 Days

Get your company in front of buyers, manufacturers, and sourcing professionals on PharmaJungle - completely free for your first 30 days.

  • 30 days of free advertising
  • Visibility across all pages
  • Performance report with ad insights
  • No setup or registration fee
Claim Your Free Ad

Exclusive introductory offer for new advertisers

Related Databases
3 of 6 have records
EDQM CEP 6 Japan DMF 2 NDC Database 86
KDMF No records
FDA Approved Drugs Database No records
Drug Prices in Switzerland No records
Product Type Breakdown
45 total
  • DRUG FOR FURTHER PROCESSING
Official Source

NDC data is based on publicly available National Drug Code information from the U.S. Food and Drug Administration (FDA).

Visit FDA NDC Directory
Record Details Preview

Click "View Details" on any record above to expand full details inline.

Substance

NICOTINE

Identifiers

NDC: 11014-0742
DEA Schedule:

Official FDA Data

Based on publicly available FDA NDC information

National Drug Code

Structured NDC product information

Product Information

Drug, labeler and marketing data

Easy to Explore

Search and filter NDC records

NDC data is based on publicly available U.S. Food and Drug Administration (FDA) National Drug Code information.
PharmaJungle
Buying request

Post your requirement

Get offers from suppliers

  • Reach pharmaceutical suppliers
  • Specify quality standard and quantity
  • Set your shipping preference
  • Receive offers directly
  • Listed on our marketplace

Your product details and requirements may be published on the marketplace.

PharmaJungle

Create a New Buying Request

Fields marked with * are mandatory.

Please enter quantity.
Please select a unit.
Please select quality standard.
Please select request type.
Please provide product specifications.
Please enter additional details.
Please select shipping preference.
Notice: By submitting this buying request, the provided product details and requirements may be published publicly on our marketplace.
Login to Submit